Background Many extrapulmonary neoplasms metastasize to the lungs. We conducted a retrospective review of all patients who underwent pulmonary metastasectomy for oligometastatic disease at two centres in order determine long-term outcomes. Methods The study institutions' thoracic surgery databases were searched from 2000 2017. Results There total 476 metastasectomy. Mean age time was 57.2 ± 15....

BACKGROUND Prostate cancer most commonly metastasizes to bones or lymph nodes, and metastatic prostate cancer is suggestive of disseminated disease. Metastatic disease is usually not amenable to surgery. CASE PRESENTATION The current report presents a unique case of in which the excision of a solitary pulmonary metastasis resulted in undetectable prostate-specific antigen. CONCLUSION This c...

Presenter: Annabelle Jones MD | Brigham and Women's Hospital Background: In select patients with colorectal cancer liver metastases (CRLM), metastasectomy curative-intent has been found to be associated a 5-year overall survival that is greater than 50%. Despite recent advancements, it estimated only half of potentially resectable CRLM are undergoing metastasectomy. Previous studies have demons...

: In this special series devoted to lung metastasectomy, our purpose is provide a thought provoking challenge widespread clinical practice. The forms of evidence recognised as most trustworthy in health care research are randomised controlled trials, meta-analysis trials and expert analysis big databases. These have all been used investigate the effectiveness metastasectomy its commonest applic...

ObjectivesAlthough colorectal cancer bowel segment location has been shown to independently predict the outcomes in early stage disease, it not previously studied setting of pulmonary metastases. We sought determine whether affects survival after metastasectomy.MethodsPatients who had undergone metastasectomy for at a single institution from 2011 2018 were reviewed. Univariable and multivariabl...

Background To assess the prognostic and predictive factors of time to treatment failure (TTF) and overall survival (OS), respectively, in patients with metachronous metastatic renal cell carcinoma (mRCC) who were treated with targeted agents. Materials and Methods We retrospectively reviewed metachronous mRCC patients, defined as individuals diagnosed with metastatic disease >3 months after i...

BACKGROUND Long-term survival after resection of metastases from pancreatic ductal adenocarcinoma is rare. CASE PRESENTATION A 54-year-old man underwent pancreaticoduodenectomy (PD) for pancreatic ductal adenocarcinoma (PDAC) with UICC staging pT3N1M0 followed by adjuvant chemotherapy with gemcitabine (GEM). Three years after radical resection of the primary tumor, a tiny nodule was found in ...

BACKGROUND The possible benefits of the surgical resection of multiple metastases in rare sites from colorectal cancer (CRC) are still unclear. Therefore, more cases are needed to investigate the surgical outcomes of these diseases. A very rare case in which the simultaneous resection of both the metachronous retroperitoneal lymph node and pancreatic metastases from rectal cancer was successful...

BACKGROUND Resection of the metastatic site is indicated but not always possible in patients with metastatic colorectal cancer (mCRC) who achieve a partial or complete response (CR) to induction systemic treatment. CR after systemic treatment alone is uncommon, and even patients with radiologic CR after induction chemotherapy harbour persistent macroscopic or microscopic residual disease in mor...